Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ID Pharma

ID Pharma
2003 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of pharmaceutical medicines, vaccines and other pharmaceutical products. The company's products contribute to original research and development on the forefront of life science and businesses that will cure intractable diseases and helps patients to live a healthy life.

Formerly Known As
DNAVEC Corp.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Parent Company
I'rom Group Company
Primary Office
  • Techno Park Oho
  • 6 Ohkubo, Tsukuba
  • Ibaraki, 300-2611
  • Japan

ID Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ID Pharma‘s full profile, request access.

Request full access to PitchBook

ID Pharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Tsugmine Shu Ph.D President